YOLO News and Press, AdvisorShares Pure Cannabis From 08/12/22

New York will begin accepting applications for operating adult-use cannabis dispensaries in two weeks, but only from those who have been impacted by a marijuana offense . The New York Office of Cannabis Management will only accept applications from "justice involved" individua...

Emily Paxhia and Hirsh Jain catch us up on the California cannabis market and beyond. Getting out of the death spiral but not quite out of the woods yet. Elimination of cultivation tax, but other taxes remain. What parts of the supply chain will benefit? Cannabis pricing, lega...

Green Thumb is one of the strongest companies in the still emerging cannabis industry. Second quarter results confirm Green Thumb's strength and path to success. With a share price disconnected from fundamentals, investors should maintain or increase their allocation to Green Thum...

Jon DeCourcey shares how his cannabis investing philosophy has shifted over the past few months. Micro vs macro perspective, risk on vs risk off environment. What is going on in Washington? Is there reason for more optimism on political front? Moving pieces of continued cannab...

Banking legislation push is getting a lot of buzz. SAFE passage would be a game changer for valuations with large MSOs disproportionately benefitting with initial stock gains. Within that group, believe Ascend and AYR should be considered for near-term investment. Both are as well...

We now have 37 states, plus Washington DC, that offer some form of medical or adult-use cannabis. MSOS is the largest cannabis ETF with approximately $650 million in assets. YOLO is the first actively-managed cannabis ETF domiciled in the United States. While ETFs are po...

Jon DeCourcey shares how his cannabis investing philosophy has shifted over the past few months. Micro vs macro perspective, risk on vs risk off environment. What is going on in Washington? Is there reason for more optimism on political front? Moving pieces of continued cannab...

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism. Valuations are low, but there's good news across the US. These stocks are really cheap. Mistake to assume margins will go down. ...

Benchmark has downgraded Tilray Brands ( NASDAQ: TLRY ) to sell from buy as the company's fiscal 2022 Q4 results indicated the cannabis licensed producer is continuing to lose market share in Canada. The firm sees dark clouds over the Canadian cannabis industry overall. ...

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism. Valuations are low, but there's good news across the US. These stocks are really cheap. Mistake to assume margins will go down. ...